25 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
to which the Company is subject, the purpose of which is to protect the privacy of individuals or prescribers;
(d)the Patient Protection … complied and are presently in material compliance with all internal and external privacy policies, contractual obligations, industry standards, applicable
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
.
9.Data Privacy Consent.
In order to administer the Plan and this agreement and to implement or structure future equity grants, the Company, its … all Relevant Information; (b) waives any privacy rights the Participant may have with respect to the Relevant Information; (c) authorizes the Relevant
8-K
EX-10.1
wh0o2xm7 sthfc
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-1.2
xc8ymg
9 Nov 22
Shelf registration
4:15pm
10-K
poeph
1 Mar 22
Annual report
4:07pm
10-Q
y6q 22aop
2 Dec 21
Quarterly report
4:15pm
424B4
skntap ae79
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.6
ubg8n3 p6t061xs5v
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-1.1
e8yff7xr
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
77drxv7h
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.7
76ps8dzwgzgeffnlx
18 Oct 21
IPO registration (amended)
6:04am